Solid Biosciences (SLDB) Assets: 2017-2024
Historic Assets for Solid Biosciences (SLDB) over the last 7 years, with Sep 2024 value amounting to $211.8 million.
- Solid Biosciences' Assets rose 14.67% to $211.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $211.8 million, marking a year-over-year increase of 14.67%. This contributed to the annual value of $164.9 million for FY2023, which is 36.62% down from last year.
- Latest data reveals that Solid Biosciences reported Assets of $211.8 million as of Q3 2024, which was down 8.29% from $231.0 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Assets registered a high of $285.3 million during Q1 2021, and its lowest value of $40.5 million during Q3 2020.
- Moreover, its 3-year median value for Assets was $208.5 million (2022), whereas its average is $212.4 million.
- In the last 5 years, Solid Biosciences' Assets crashed by 69.05% in 2020 and then skyrocketed by 514.51% in 2021.
- Over the past 5 years, Solid Biosciences' Assets (Quarterly) stood at $171.2 million in 2020, then soared by 35.76% to $232.4 million in 2021, then rose by 11.99% to $260.3 million in 2022, then plummeted by 36.62% to $164.9 million in 2023, then increased by 14.67% to $211.8 million in 2024.
- Its Assets was $211.8 million in Q3 2024, compared to $231.0 million in Q2 2024 and $248.7 million in Q1 2024.